Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-deoxynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid species

Overview of attention for article published in Investigational New Drugs, December 2016

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 4,840 followers.

RT @oncologiavet: Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent IB-DNQ in cats https://t.…

Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent IB-DNQ in cats https://t.co/2iGFi2kfC0